Company news
Bio-Gene Technology Ltd. news in 2026
Bio-Gene Technology Ltd.'s news releases, calls and decks from 2026, newest first.
Notice of Annual General Meeting/Proxy Form
October 29, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
October 29, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
October 29, 2026
Proposed issue of securities - BGT
October 27, 2026
Bio-Gene Receives $343,000 R&D Tax Incentive
October 18, 2026
Date of 2026 Annual General Meeting
October 11, 2026
Flavocide efficacy results against deer ticks published
October 6, 2026
Appendix 4E and 2026 Annual Report
August 27, 2026
Corporate Governance Statement
August 27, 2026
Appendix 4G
August 27, 2026
Change in substantial holding
August 26, 2026
Change in substantial holding
August 26, 2026
Notification regarding unquoted securities - BGT
August 9, 2026
Change of Director's Interest Notice x 4
August 9, 2026
Placement Completed and Cleansing Notice
August 9, 2026
Application for quotation of securities - BGT
August 9, 2026
Application for quotation of securities - BGT
August 9, 2026
Application for quotation of securities - BGT
August 9, 2026
Results of Meeting
August 4, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
July 30, 2026
Results of Placement
May 25, 2026
Sumitomo & Nakashima to launch Qcide products in Japan
March 15, 2026
Regulatory Development of Flavocide
March 2, 2026
Appendix 4D and Half-Year Accounts 31 December 2025
February 23, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
Decks in 2026
- Investor Presentation (May 2026)
Investor deck · 20 slides · May 26, 2026
- Ignite Investment Summit Singapore 2026
Conference · 21 slides · Apr 20, 2026
- NWR Virtual Healthcare Conference 2026
Conference · 18 slides · Mar 26, 2026